Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Tipo de estudio
Intervalo de año de publicación
1.
Age (Dordr) ; 38(1): 26, 2016 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-26867806

RESUMEN

Cellular senescence is a multifactorial phenomenon of growth arrest and distorted function, which has been recognized as an important feature during tumor suppression mechanisms and a contributor to aging. Senescent cells have an altered secretion pattern called Senescence-Associated Secretory Phenotype (SASP) that comprises a complex mix of factors including cytokines, growth factors, chemokines, and matrix metalloproteinases. SASP has been related with local inflammation that leads to cellular transformation and neurodegenerative diseases. Various pathways for senescence induction have been proposed; the most studied is replicative senescence due to telomere attrition called replicative senescence (RS). However, senescence can be prematurely achieved when cells are exposed to diverse stimuli such as oxidative stress (stress-induced premature senescence, SIPS) or proteasome inhibition (proteasome inhibition-induced premature senescence, PIIPS). SASP has been characterized in RS and SIPS but not in PIIPS. Hence, our aim was to determine SASP components in primary lung fibroblasts obtained from CD-1 mice induced to senescence by PIIPS and compare them to RS and SIPS. Our results showed important variations in the 62 cytokines analyzed, while SIPS and RS showed an increase in the secretion of most cytokines, and in PIIPS only 13 were incremented. Variations in glutathione-redox balance were also observed in SIPS and RS, and not in PIIPS. All senescence types SASP displayed a pro-inflammatory profile and increased proliferation in L929 mice fibroblasts exposed to SASP. However, the behavior observed was not exactly the same, suggesting that the senescence induction pathway might encompass dissimilar responses in adjacent cells and promote different outcomes.


Asunto(s)
Envejecimiento , Senescencia Celular/fisiología , Citocinas/metabolismo , Pulmón/citología , Estrés Oxidativo , Animales , Animales Recién Nacidos , Proliferación Celular , Células Cultivadas , Daño del ADN , Fibroblastos/citología , Fibroblastos/metabolismo , Pulmón/crecimiento & desarrollo , Pulmón/metabolismo , Ratones , Fenotipo , Telómero/metabolismo
2.
J Appl Toxicol ; 21(4): 323-9, 2001.
Artículo en Inglés | MEDLINE | ID: mdl-11481667

RESUMEN

A human fetal hepatic cell line (WRL-68) was used as a model to study the damage produced by mercury. The Hg(II) uptake by WRL-68 cells was found to be in a biphasic manner with a rapid initial uptake phase lasting about 5 min, followed by a sustained phase of slower accumulation. Distribution of mercury was studied and mitochondria were found to be the major target for mercury in this cell line (48%), followed by nuclei (38%), cytosol (8%) and microsomes (7%). Mitochondrial morphological damage after mercury treatment was observed by transmission electron microscopy. To determine if the toxic effect of mercury on mitochondrial bioenergetics was direct or indirect, mitochondria were isolated from WRL-68 cells after 1 h of pre-incubation with 0.5 microM HgCl(2). Oxygen consumption was quantified in two sets of experiments: in the presence of classical mitochondrial respiratory inhibitors; and in the presence of oligomycin. No significant difference was found in respiration with classical inhibitors, indicating that mercury does not affect directly the mitochondrial respiratory chain. However, mitochondria of Hg-treated cells were not inhibited when oligomycin was added, probably due to an uncoupling effect. This effect was prevented with dithiothreitol (DTT) treatment. A possible explanation for mercury's effect on mitochondria and its relation with oxidative stress is presented.


Asunto(s)
Ditiotreitol/farmacología , Cloruro de Mercurio/toxicidad , Mercurio/metabolismo , Mitocondrias Hepáticas/efectos de los fármacos , Mitocondrias Hepáticas/metabolismo , Desacopladores/toxicidad , Adenosina Difosfato/metabolismo , Adenosina Trifosfatasas/metabolismo , Línea Celular , Supervivencia Celular/efectos de los fármacos , Células Cultivadas , Transporte de Electrón/efectos de los fármacos , Inhibidores Enzimáticos/farmacología , Humanos , Cloruro de Mercurio/farmacocinética , Microscopía Electrónica , Mitocondrias Hepáticas/ultraestructura , Oligomicinas/farmacología , Consumo de Oxígeno/efectos de los fármacos , Cianuro de Potasio/farmacología , Rotenona/farmacología , Fracciones Subcelulares/metabolismo , Desacopladores/farmacocinética
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA